Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Singh Brother Feud: How Recent Developments may end all TIES

      Singh Brother Feud: How Recent Developments may end all TIES

      Farhat Nasim10 Dec 2018 9:45 AM IST
      In the latest twist to the Singh brother feud, Malvinder Singh in a video circulated on social media had claimed that he was hit by Shivinder.NEW...
      USFDA recommends regulatory action after Jubilant Life Roorkee plant inspection

      USFDA recommends regulatory action after Jubilant Life Roorkee plant inspection

      Farhat Nasim10 Dec 2018 9:30 AM IST
      New Delhi: The US health regulator has recommended a regulatory or administrative action after the inspection of Roorkee manufacturing facility of...
      Zydus Wellness to raise Rs 2,575 crore via share sale

      Zydus Wellness to raise Rs 2,575 crore via share sale

      Farhat Nasim9 Dec 2018 10:01 AM IST
      New Delhi: Zydus Wellness on Thursday said it is planning to raise Rs 2,574.99 crore through issue of shares on a preferential basis to fund the...
      Roche lung cancer combo treatment wins FDA approval

      Roche lung cancer combo treatment wins FDA approval

      Farhat Nasim9 Dec 2018 9:47 AM IST
      Swiss drugmaker Roche Holding AG said that its Tecentriq immunotherapy in combination with Avastin and chemotherapy was approved by the U.S. Food and...
      CDSCO issues PUBLIC NOTICE asking for feedback on online portal SUGAM

      CDSCO issues PUBLIC NOTICE asking for feedback on online portal SUGAM

      Farhat Nasim9 Dec 2018 9:25 AM IST
      All stakeholders of SUGAM are requested to provide their valuable feedback as per enclosed format with suggestions about the short-term, medium-term...
      Moderna to sell $618 million worth shares in IPO, braving market jitters

      Moderna to sell $618 million worth shares in IPO, braving market jitters

      Farhat Nasim9 Dec 2018 9:17 AM IST
      New Delhi: Moderna Inc is set to sell around $618 million in shares in its initial public offering (IPO) on Thursday, a person familiar with the...
      Libya to launch vaccine campaign overseen by WHO

      Libya to launch vaccine campaign overseen by WHO

      Farhat Nasim9 Dec 2018 9:00 AM IST
      Tripoli: Libya is set to launch a vaccine campaign overseen by the World Health Organization to vaccinate more than 2.7 million children after months...
      Final regulations on e pharmacy likely by December-end, says DCGI

      Final regulations on e pharmacy likely by December-end, says DCGI

      Farhat Nasim8 Dec 2018 10:29 AM IST
      In September, the Union health ministry came out with draft rules on the sale of drugs by e pharmacies. Panaji: The union government is expected to...
      NCLT dismisses HDFC insolvency plea against RHC Holding

      NCLT dismisses HDFC insolvency plea against RHC Holding

      Farhat Nasim8 Dec 2018 10:15 AM IST
      NEW DELHI: National Company Law Tribunal (NCLT) on Thursday dismissed HDFC Ltd's insolvency plea against RHC Holding, observing that the non-banking...
      Alembic Pharma plans to get upto Rs 500 crore through NCDs

      Alembic Pharma plans to get upto Rs 500 crore through NCDs

      Farhat Nasim7 Dec 2018 9:50 AM IST
      New Delhi: Drug firm Alembic Pharma on Thursday said it plans to raise up to Rs 500 crore through issue of non-convertible debentures (NCDs) on...
      Novartis to launch epinephrine-rival to EpiPens

      Novartis to launch epinephrine-rival to EpiPens

      Farhat Nasim7 Dec 2018 9:30 AM IST
      New Delhi: Novartis AG said its U.S. unit Sandoz Inc will launch Adamis Pharmaceuticals Corp's emergency allergy shots next year in the United States,...
      Lupin gets 22 observations for MP plant

      Lupin gets 22 observations for MP plant

      Farhat Nasim5 Dec 2018 5:02 PM IST
      Lupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalosporin API...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok